WARE et al v. JANSSEN PHARMACEUTICALS, INC. et al
| TOM WARE and CAROL WARE |
| JANSSEN PHARMACEUTICALS INC, BAYER HEALTHCARE PHARMACEUTICALS INC., JANSSEN PHARMACEUTICA INC, ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC., BAYER US L.L.C., JOHNSON & JOHNSON doing business as ALZA CORPORATION doing business as JANSSEN ORTHO LLC doing business as JANSSEN RESEARCH & DEVELOPMENT LLC doing business as ORTHO-MCNEIL PHARMACEUTICALS, INC., BAYER CORPORATION, BAYER PHARMACEUTICALS CORPORATION and JOHN DOE DRUG COMPANY DEFENDANTS #1-10 |
| ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION |
| 2:2021cv00508 |
| January 11, 2021 |
| US District Court for the District of New Jersey |
| Edward S Kiel |
| Brian R Martinotti |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 11, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 27 Clerk's Notice to Counsel. (gh, ) |
| Filing 26 Certified Copy of Transfer Order and docket received, Case transferred in from District of Pennsylvania Eastern; Case Number 2:20-cv-04053. Original file certified copy of transfer order and docket sheet received. |
| Judge Brian R. Martinotti and Magistrate Judge Edward S. Kiel added. (gh, ) |
| Member Case Transferred on 1/11/21 from the EDPA for MDL 2973 ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION (gh, ) |
| This case is part of MDL2973. Parties are expected to review and abide by all prior orders entered in this MDL, which can be found #Here (gh, ) |
| Filing 25 Conditional Transfer Order (MDL 2973) THAT THE ACTIONS LISTED ON SCHEDULE A AND PENDING OUTSIDE THE DISTRICT OF NEW JERSEY ARE TRANSFERRED TO THE DISTRICT OF NEW JERSEY AND WITH THE CONSENT OF THAT COURT, ASSIGNED TO THE HONORABLE BRIAN R. MARTINOTTI FOR COORDINATED OR CONSOLIDATED PROCEEDINGS WITH THE ACTIONS PENDING THERE AND LISTED IN SCHEDULE A; ETC. (JL ) |
| Filing Fee for PRO HAC VICE by CAROL WARE, TOM WARE. (Filing Fee $40; PPE221283)(Filing fee $ 40.) (jaa, ) |
| Filing 24 AMENDED ANSWER to Complaint AND AFFIRMATIVE DEFENSES by JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON. (MILLER, CHANDA) |
| Filing 23 Notice of Filing of Official Transcript with Certificate of Service re #22 Transcript - PDF,, 11/6/20 Entered and Copies Emailed and Mailed.. (jaa, ) |
| Filing 22 TRANSCRIPT of JOINT STATUS REPORT HEARING VIA VIDEOCONFERENCE held on 10/29/20, before Judge WENDY BEETLESTONE. Court Reporter/Transcriber KATHLEEN FELDMAN. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER.. Redaction Request due 11/27/2020. Redacted Transcript Deadline set for 12/7/2020. Release of Transcript Restriction set for 2/4/2021. (jaa, ) |
| Filing 21 NOTICE OF ALL JANSSEN MATTERS ZOOM STATUS CONFERENCE: CONFERENCE SET FOR 12/7/2020 10:00 AM VIA ZOOM VIDEO CONFERENCE, COUNSEL SHALL CONFER AS TO WHO WILL SCHEDULE AND CIRCULATE ZOOM DIAL IN INFORMATION TO CHAMBERS AT chambers_of_judge_beetlestone@paed.uscourts.govBEFORE HONORABLE WENDY BEETLESTONE.(amw, ) |
| REG. ORDER ENTRY #4 TO ALL PARTIES ON 10/26/20. (jaa, ) |
| Filing 20 ANSWER to Complaint and Affirmative Defenses by JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON.(MILLER, CHANDA) |
| Filing 19 ANSWER to Complaint and Affirmative Defenses by BAYER CORPORATION, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER U.S. L.L.C..(MILLER, CHANDA) |
| Filing 18 Disclosure Statement Form pursuant to FRCP 7.1 with Certificate of Service by BAYER CORPORATION, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER U.S. L.L.C..(MILLER, CHANDA) |
| Filing 17 NOTICE of Appearance by CHANDA A MILLER on behalf of BAYER CORPORATION, BAYER U.S. L.L.C. with Jury Demand and Certificate of Service(MILLER, CHANDA) |
| Filing 16 NOTICE of Appearance by DAVID F. ABERNETHY on behalf of BAYER CORPORATION, BAYER U.S. L.L.C. with Jury Demand and Certificate of Service(ABERNETHY, DAVID) |
| Filing 15 AFFIDAVIT of Service by Matthew J. Honnold re: served Summons and Complaint upon Janssen Pharmaceuticals, Inc. by E-Mail on 10/15/2020 (KESSLER, RAYNA) |
Filing 14
STIPULATION AND ORDER THAT BAYER CORPORATION; BAYER U.S. L.L.C. THAT THE DEADLINE TO FILE THEIR RESPONSE TO THE COMPLAINT SHALL BE EXTENDED TO 10/16/20; ETC.. SIGNED BY HONORABLE WENDY BEETLESTONE ON 10/13/20. 10/13/20 ENTERED AND E-MAILED.(JL)
|
| Filing 13 AFFIDAVIT of Service by Matthew J. Honnold re: served Summons and Complaint upon Johnson & Johnson by E-Mail on 8/27/2020 (KESSLER, RAYNA) |
| Filing 12 AFFIDAVIT of Service by STATUS, L.L.C. re: served Summons and Complaint upon Bayer U.S. LLC by Personal Service on 9/22/2020, answer due 10/13/2020. (KESSLER, RAYNA) Modified on 10/9/2020 (tjd). |
| Filing 11 AFFIDAVIT of Service by STATUS, L.L.C. re: served Summons and Complaint upon Bayer Corporation by Personal Service on 9/22/2020, answer 10/13/2020. (KESSLER, RAYNA) Modified on 10/9/2020 (tjd). |
| Filing 10 AFFIDAVIT of Service by STATUS, L.L.C. re: served Summons and Complaint upon Bayer Healthcare Pharmaceuticals, Inc. by Personal Service on 8/31/2020 (KESSLER, RAYNA) |
| Filing 9 APPLICATION for Admission Pro Hac Vice of Ian S. Millican, Esq. by CAROL WARE, TOM WARE.. (Attachments: #1 Supplement Sponsor's Statement, #2 Text of Proposed Order, #3 Certificate of Service)(KESSLER, RAYNA) |
| Filing 8 NOTICE OF STATUS CONFERENCE - SET FOR THURSDAY OCTOBER 29, 2020 AT 2:00 P.M. VIA ZOOM VIDEO CONFERENCE - COUNSEL SHALL CONFER AS TO WHO SHALL SCHEDULE AND CIRCULATE DIAL IN INFORMATION TO CHAMBERS AT chambers_of_judge_beetlestone@paed.uscourts.gov.(amw, ) |
|
Filing 7
ORDER DENYING #6 MOTION TO STAY BY HONORABLE WENDY BEETLESTONE ON 09/29/2020.09/29/2020 ENTERED AND COPIES E-MAILED.(amw, )
|
| Filing 6 MOTION to Stay ALL PROCEEDINGS PENDING A DECISION ON MDL CENTRALIZATION filed by JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON.Memorandum, Certificate of Service and Exhibit A.(MILLER, CHANDA) |
| Filing 5 Disclosure Statement Form pursuant to FRCP 7.1 with Certificate of Service by JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON.(MILLER, CHANDA) |
|
Filing 4
STIPULATION AND ORDER THAT TO EXTEND TIME FOR CERTAIN DEFENDANTS TO RESPOND TO COMPLAINT. SIGNED BY HONORABLE WENDY BEETLESTONE ON 9/23/20. 9/23/20 ENTERED AND COPIE E-MAILED. *NOT MAILED TO UNREPS. (jaa, )
|
| Filing 3 NOTICE of Appearance by CHANDA A MILLER on behalf of JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON with Jury Demand and Certificate of Service(MILLER, CHANDA) |
| Filing 2 NOTICE of Appearance by DAVID F. ABERNETHY on behalf of JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON with Jury Demand and Certificate of Service(ABERNETHY, DAVID) |
| Summons Issued as to BAYER CORPORATION, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER U.S. L.L.C., JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON. E-MAILED To: COUNSEL on 8/20/2020 (bw, ) |
| DEMAND for Trial by Jury by CAROL WARE, TOM WARE. (fb) |
| Filing 1 COMPLAINT against BAYER CORPORATION, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER U.S. L.L.C., JOHN DOE DRUG COMPANY #1-10, JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON ( Filing fee $ 400 receipt number 0313-14507395.), filed by CAROL WARE, TOM WARE. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet, #4 Designation Form, #5 Case Management Track Form)(KESSLER, RAYNA) Modified on 8/20/2020 (fb). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
